CN109916868B - A β-cyclodextrin functionalized carbon dot material - Google Patents
A β-cyclodextrin functionalized carbon dot material Download PDFInfo
- Publication number
- CN109916868B CN109916868B CN201910186997.7A CN201910186997A CN109916868B CN 109916868 B CN109916868 B CN 109916868B CN 201910186997 A CN201910186997 A CN 201910186997A CN 109916868 B CN109916868 B CN 109916868B
- Authority
- CN
- China
- Prior art keywords
- cyclodextrin
- dot material
- functionalized carbon
- testosterone
- carbon dot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000858 Cyclodextrin Polymers 0.000 title claims abstract description 32
- 239000001116 FEMA 4028 Substances 0.000 title claims abstract description 27
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title claims abstract description 27
- 235000011175 beta-cyclodextrine Nutrition 0.000 title claims abstract description 27
- 229960004853 betadex Drugs 0.000 title claims abstract description 27
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 229910052799 carbon Inorganic materials 0.000 title claims abstract description 19
- 239000000463 material Substances 0.000 title claims abstract description 19
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims abstract description 70
- 229960003604 testosterone Drugs 0.000 claims abstract description 35
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims abstract description 17
- 150000001408 amides Chemical class 0.000 claims abstract description 3
- 238000006482 condensation reaction Methods 0.000 claims abstract description 3
- 239000007850 fluorescent dye Substances 0.000 claims description 21
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 8
- 239000008363 phosphate buffer Substances 0.000 claims description 7
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 6
- OZBFLQITCMCIOY-FOUAGVGXSA-N OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO OZBFLQITCMCIOY-FOUAGVGXSA-N 0.000 claims description 5
- 238000000502 dialysis Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- JIXIGMAACRMMNM-UHFFFAOYSA-M cyclopenta-1,3-diene;cyclopenta-1,3-dien-1-ylmethyl(trimethyl)azanium;iron(2+);iodide Chemical compound [Fe+2].[I-].C=1C=C[CH-]C=1.C[N+](C)(C)C[C-]1C=CC=C1 JIXIGMAACRMMNM-UHFFFAOYSA-M 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 abstract description 8
- 238000012544 monitoring process Methods 0.000 abstract description 4
- 239000012472 biological sample Substances 0.000 abstract description 3
- 239000003270 steroid hormone Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000005284 excitation Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 239000012491 analyte Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 2
- DBPWSSGDRRHUNT-UHFFFAOYSA-N 17alpha-hydroxy progesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)(O)C1(C)CC2 DBPWSSGDRRHUNT-UHFFFAOYSA-N 0.000 description 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 2
- 229960005471 androstenedione Drugs 0.000 description 2
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 229960003399 estrone Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 description 2
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 2
- 229960004296 megestrol acetate Drugs 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
本发明公开了一种β‑环糊精功能化碳点材料。该碳点材料是通过N,S掺杂碳点(N,S‑CDs)基于酰胺缩合反应将β环糊精键合于碳点表面而制得。能够应用于环境监测领域以及生物样本中固醇类激素物质的水平监测,尤其是对于睾酮的选择性分析方法。The invention discloses a β-cyclodextrin functionalized carbon dot material. The carbon dot material is prepared by bonding β-cyclodextrin to the surface of the carbon dots based on the amide condensation reaction of N, S-doped carbon dots (N,S-CDs). It can be applied to the field of environmental monitoring and the level monitoring of steroid hormones in biological samples, especially for the selective analysis of testosterone.
Description
本申请是申请号为“201710206063.6”、申请日为2017年3月31日、发明名称为“β-环糊精功能化碳点材料及其应用于检测睾酮的方法”的发明专利申请的分案申请。This application is a division of an invention patent application with the application number "201710206063.6", the application date being March 31, 2017, and the invention title "β-cyclodextrin functionalized carbon dot material and its application in the detection of testosterone" Application.
技术领域technical field
本发明总体涉及环境监测领域以及生物、食品样本中固醇类激素物质的水平监测,尤其是对于睾酮的选择性分析方法。The present invention generally relates to the field of environmental monitoring and the level monitoring of steroid hormone substances in biological and food samples, especially to a selective analysis method for testosterone.
背景技术Background technique
睾酮作为非常重要的固醇类雄性激素,其本身不仅作为调控因子广泛参与到生物新陈代谢以及生殖发育的过程中,其在生物体中水平的高低与多种生理指标甚至疾病,诸如二型糖尿病、前列腺癌、冠状动脉疾病和肾结石相关,由于睾酮的重要生理作用使其也被应用于医药和兽药中从而通过医疗、生活和农业污水排放进入环境中。而现有的对于睾酮的检测分析主要依靠HPLC、GC-MS、HPLC-MS/MS等高性能、精密仪器。虽然对于生物样本有基于酶联免疫反应的ELISA快速检测试剂盒可以应用于睾酮含量的分析,但这样分析需要对于样品的前处理不能做到原位(in situ)的检测。因此一种高效简便可以in situ可视化分析睾酮水平的方法不仅对于生化检测意义重大,更可以拓展应用到环境以及食品安全的检测中。As a very important steroid androgen, testosterone itself is not only widely involved in the process of biological metabolism and reproductive development as a regulatory factor, but its level in the organism is related to various physiological indicators and even diseases, such as type 2 diabetes, Prostate cancer, coronary artery disease, and kidney stones are associated with testosterone, which is also used in medicine and veterinary medicine due to its important physiological role and enters the environment through medical, domestic and agricultural wastewater discharges. The existing detection and analysis of testosterone mainly rely on high-performance and precise instruments such as HPLC, GC-MS, and HPLC-MS/MS. Although there are ELISA-based rapid detection kits for biological samples that can be applied to the analysis of testosterone content, such analysis requires the pretreatment of the samples and cannot be detected in situ. Therefore, an efficient and simple method that can visualize testosterone levels in situ is not only of great significance for biochemical detection, but also can be extended to the detection of environment and food safety.
发明内容SUMMARY OF THE INVENTION
本发明要解决的技术问题是合成β环糊精功能化的碳点,基于其对于睾酮的选择性识别能力从而提供一种方便快捷,结果准确的液体样本睾酮的分析方法。The technical problem to be solved by the present invention is to synthesize β-cyclodextrin-functionalized carbon dots, and to provide a convenient, quick, and accurate liquid sample testosterone analysis method based on its selective recognition ability for testosterone.
根据本发明的第一方面,提供一种β-环糊精功能化碳点材料,该碳点材料是通过N,S掺杂碳点(N,S-CDs)基于酰胺缩合反应将β环糊精键合于碳点表面而制得。According to a first aspect of the present invention, a β-cyclodextrin functionalized carbon dot material is provided, the carbon dot material is made of N, S-doped carbon dots (N, S-CDs) based on an amide condensation reaction. It is prepared by fine bonding to the surface of carbon dots.
首先,环糊精作为功能性识别体,根据其本身组成它们的吡喃葡萄糖分子数的不同分为有α-环糊精,β-环糊精,γ-环糊精,δ-环糊精四种,其中以前三种最为常见,考虑到目标分子的体积故只有6个吡喃葡萄糖分子的α-环糊精由于其内部空腔体积太小不适宜使用,同理γ-环糊精,δ-环糊精虽然内部空间足够容纳目标分子但是由于其本身空间太大后相应的空间位阻作用位点减少,从而使分子识别能力降低,因此选用β-环糊精。First of all, cyclodextrins, as functional recognizers, can be divided into α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin, δ-cyclodextrin according to the number of glucopyranose molecules that compose them. There are four kinds, of which the first three are the most common. Considering the volume of the target molecule, α-cyclodextrin with only 6 glucopyranose molecules is not suitable for use because its internal cavity volume is too small. Similarly, γ-cyclodextrin, Although the internal space of δ-cyclodextrin is enough to accommodate the target molecule, the corresponding steric hindrance sites are reduced due to its too large space, which reduces the molecular recognition ability, so β-cyclodextrin is selected.
其次,在侧链官能团选择上,首先末端必须含有易于碳点表面羧基反应的基团,故选择氨基,此外侧本身长度不能太长,不然不利于光激发电子转移,因此选择单(6-氨基-6-去氧)基为侧链基团Secondly, in the selection of side chain functional groups, first of all, the end must contain a group that is easy to react with the carboxyl group on the surface of the carbon point, so amino group is selected, and the length of the outer side itself should not be too long, otherwise it is not conducive to photo-excited electron transfer, so choose single (6-amino group) -6-Deoxy) group is a side chain group
综上所述优选情况下,所述β环糊精为单(6-氨基-6-去氧)β环糊精。In summary, preferably, the β-cyclodextrin is mono(6-amino-6-deoxy)β-cyclodextrin.
具体情况下:先将N,S-CDs溶解在去离子水中,然后加入1-乙基-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐(EDC.HCL)和N-羟基丁二酰亚胺(NHS),搅拌一定时间后,加入单(6-氨基-6-去氧)β环糊精,继续搅拌反应,所得产物使用透析袋进行透析,最后冷冻干燥得到所述β环糊精功能化碳点材料。Specific case: First dissolve N,S-CDs in deionized water, then add 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC.HCL) and N- Hydroxysuccinimide (NHS), after stirring for a certain period of time, adding mono(6-amino-6-deoxy) β-cyclodextrin, and continuing to stir the reaction, the obtained product was dialyzed using a dialysis bag, and finally freeze-dried to obtain the described β-cyclodextrin functionalized carbon dot material.
优选情况下,考虑EDC.HCL的催化机理,使NHS略微过量使得EDC.HCL与NHS的摩尔比在1:1.5到1:2之间,故N,S-CDs与EDC.HCL、NHS、单(6-氨基-6-去氧)β环糊精的物质配比范围为质量比(1:3:3.5:10)到(1:3:4:20)之间。Preferably, considering the catalytic mechanism of EDC.HCL, the NHS is slightly excessive so that the molar ratio of EDC.HCL to NHS is between 1:1.5 and 1:2, so N,S-CDs is comparable to EDC.HCL, NHS, monolithic The material ratio of (6-amino-6-deoxy) β-cyclodextrin ranges from the mass ratio (1:3:3.5:10) to (1:3:4:20).
根据本发明的第二方面,提供一种检测睾酮的方法,包括以下步骤:According to a second aspect of the present invention, there is provided a method for detecting testosterone, comprising the following steps:
(1)提供上述的β-环糊精功能化碳点材料;(1) providing the above-mentioned β-cyclodextrin functionalized carbon dot material;
(2)取一定量的β环糊精功能化碳点材料和(二茂铁基甲基)三甲基碘化铵(Fc+)混合溶解在一定pH的水中,振荡一定时间,形成荧光探针;(2) Take a certain amount of β-cyclodextrin functionalized carbon dot material and (ferrocenylmethyl)trimethylammonium iodide (Fc + ) to mix and dissolve in water with a certain pH, shake for a certain period of time, and form a fluorescent probe Needle;
(3)配置一系列浓度的睾酮标准液,分别加入到荧光探针系统中,振荡一定时间后,分别采用荧光光谱仪检测一定波长下的荧光强度,经线性拟合后得到标准方程;(3) configure a series of concentrations of testosterone standard solution, respectively add it to the fluorescent probe system, after oscillating for a certain period of time, use a fluorescence spectrometer to detect the fluorescence intensity at a certain wavelength, and obtain a standard equation after linear fitting;
(4)将待检测样品液加入到荧光探针系统中,振荡一定时间后采用荧光光谱仪检测一定波长下的荧光强度,与标准方程比对后得出样品液中睾酮的含量。(4) Add the sample liquid to be detected into the fluorescent probe system, and after oscillating for a certain period of time, use a fluorescence spectrometer to detect the fluorescence intensity at a certain wavelength, and compare with the standard equation to obtain the testosterone content in the sample liquid.
优选情况下,β环糊精功能化碳点材料和Fc+的配比范围为质量比为1:4到1:6之间。Preferably, the ratio of β-cyclodextrin functionalized carbon dot material to Fc + is in the range of 1:4 to 1:6 by mass.
优选情况下,所述一定pH的水为磷酸缓冲液。Preferably, the water with a certain pH is a phosphate buffer.
优选情况下,步骤(2)和(3)中所述振荡一定时间都为20min分钟以上。Preferably, the oscillation time in steps (2) and (3) is more than 20 minutes.
根据本发明的第三方面,提供一种检测睾酮的荧光探针系统,包括上述的β-环糊精功能化碳点材料、(二茂铁基甲基)三甲基碘化铵(Fc+)和磷酸缓冲液。According to a third aspect of the present invention, there is provided a fluorescent probe system for detecting testosterone, comprising the above-mentioned β-cyclodextrin functionalized carbon dot material, (ferrocenylmethyl)trimethylammonium iodide (Fc + ) and phosphate buffer.
本发明采用主客体荧光探针系统,再通过荧光光谱分析液体样本中的睾酮水平。该方法首次采用了β环糊精功能化的碳点作为选择性识别荧光探针对于目标分析物的睾酮有着很好的识别效果,并且与传统方法相比大量减少了有机溶剂的使用量,大幅缩短了前处理时间以及对于先进仪器的依赖;本发明是基于主客体荧光探针系统的荧光比色法,其对于睾酮这种固醇类雄性激素有着很好的选择性,其线性关系良好、检出限较低,可以广泛应用于液体样本中睾酮的含量水平检测,同时由于材料细胞毒性低生物兼容性好,有潜力应用于生物样本内睾酮水平的原位可视检测。The present invention adopts a host-guest fluorescent probe system, and then analyzes the testosterone level in the liquid sample through fluorescence spectrum. For the first time, this method uses β-cyclodextrin-functionalized carbon dots as a selective recognition fluorescent probe, which has a good recognition effect on the target analyte testosterone, and greatly reduces the use of organic solvents compared with the traditional method. The pretreatment time and dependence on advanced instruments are shortened; the present invention is a fluorescence colorimetric method based on a host-guest fluorescent probe system, which has good selectivity for testosterone, a steroid androgen, and has a good linear relationship, The detection limit is low, and it can be widely used in the detection of testosterone levels in liquid samples. At the same time, due to the low cytotoxicity and good biocompatibility of the material, it has the potential to be applied to the in situ visual detection of testosterone levels in biological samples.
附图说明Description of drawings
图1为采用本发明的荧光探针系统对一系列浓度的睾酮标准液的荧光光谱分析结果图。FIG. 1 is a graph showing the results of fluorescence spectrum analysis of a series of concentrations of testosterone standard solution using the fluorescent probe system of the present invention.
具体实施方式Detailed ways
一、仪器与试剂1. Instruments and Reagents
Varian CARY Eclipse荧光光谱仪(美国Varian公司)Varian CARY Eclipse Fluorescence Spectrometer (Varian, USA)
睾酮标准品(98.0%)购于上海Aladdin公司,使用时用乙醇稀释成工作溶液。雄烯二酮、黄体酮、17α-羟孕酮、醋酸甲地孕酮、雌酮、雌二酮,均购买于百灵威;其他有机溶剂均购来源于北京化工厂试剂。Testosterone standard (98.0%) was purchased from Shanghai Aladdin Company, and was diluted with ethanol to form a working solution. Androstenedione, progesterone, 17α-hydroxyprogesterone, megestrol acetate, estrone, and estradione were all purchased from Bailingwei; other organic solvents were purchased from Beijing Chemical Factory Reagents.
二、β环糊精功能化碳点材料制备及荧光探针系统的构建2. Preparation of β-cyclodextrin-functionalized carbon dots and construction of fluorescent probe system
按照文献方法由使用柠檬酸和L-半胱氨酸利用水热法制备N,S-CDs,在200摄氏度下在反应釜中反应3小时后,粗产物使用截留质量为3500Da的透析袋透析纯化,最后所得N,S-CDs在红外光谱下有着明显的1702cm-1的吸收峰证明其表面富含羧酸官能团,同时XPS能谱分析得到的284.5eV的能级峰证明其C-C键以sp2杂化后形成石墨化结构。N,S-CDs were prepared by hydrothermal method using citric acid and L-cysteine according to the literature method. After reacting in a reactor at 200°C for 3 hours, the crude product was purified by dialysis using a dialysis bag with a mass cut-off of 3500 Da. , the obtained N,S-CDs has an obvious absorption peak of 1702cm -1 in the infrared spectrum, which proves that its surface is rich in carboxylic acid functional groups, and the energy level peak of 284.5eV obtained by XPS analysis proves that its CC bond is sp 2 After hybridization, a graphitized structure is formed.
取15mg N,S-CDs溶解在30mL的去离子水中,先加入43mg 1-乙基-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐(EDC.HCL)和51mg N-羟基丁二酰亚胺(NHS)在室温下搅拌30min后加入200mg单(6-氨基-6-去氧)β环糊精后继续搅拌反应12h,所得产物使用3500Da的透析袋,透析48h,最后冷冻干燥得到最后的β环糊精功能化碳点材料。Dissolve 15mg N,S-CDs in 30mL deionized water, first add 43mg 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC.HCL) and 51mg N- Hydroxysuccinimide (NHS) was stirred at room temperature for 30min, 200mg of mono(6-amino-6-deoxy)β-cyclodextrin was added, and the reaction was continued for 12h. The resulting product was dialyzed for 48h using a 3500Da dialysis bag. Freeze-drying to obtain the final β-cyclodextrin functionalized carbon dot material.
将60μg的β环糊精功能化碳点材料和320μM的Fc+溶解在3.0mL的磷酸缓冲溶液(10mM,pH=7.4)中,在室温下振荡20min,形成荧光探针系统。60 μg of β-cyclodextrin functionalized carbon dot material and 320 μM of Fc + were dissolved in 3.0 mL of phosphate buffer solution (10 mM, pH=7.4) and shaken for 20 min at room temperature to form a fluorescent probe system.
三、荧光比色法检测睾酮水平3. Detection of testosterone level by fluorescence colorimetry
先构建标准方程(如后文所详细描述),将待检测样品液加入到荧光探针系统中,振荡20min后采用荧光光谱仪检测355nm激发波长下425nm处的荧光强度,与标准方程比对后得出样品液中睾酮的含量。First build a standard equation (as described in detail later), add the sample solution to be detected into the fluorescent probe system, and after oscillating for 20 minutes, use a fluorescence spectrometer to detect the fluorescence intensity at 425 nm at an excitation wavelength of 355 nm, and compare it with the standard equation to obtain The testosterone content in the sample solution.
四、荧光探针系统构建优化4. Construction and optimization of fluorescent probe system
荧光探针系统的合理构建对于成功检测目标分析物有着十分重要的意义,合适的体系能提高对于目标分析物的检出灵敏度,而影响探针系统的条件因素有体系pH值,淬灭剂用量以及平衡时间。The rational construction of the fluorescent probe system is of great significance for the successful detection of the target analyte. A suitable system can improve the detection sensitivity of the target analyte, and the conditional factors affecting the probe system include the pH value of the system and the amount of the quencher. and equilibration time.
1.体系pH值的影响1. The effect of pH value of the system
pH在荧光探针系统中是一个重要的因素,不同的pH可能会显著的影响荧光探针的稳定性和强度变化。pH is an important factor in fluorescent probe systems, and different pH may significantly affect the stability and intensity changes of fluorescent probes.
初步实验中,首先验证了β环糊精功能化碳点在不同pH值下的荧光稳定性,实验条件为取一定量的β环糊精功能化碳点溶解在不同pH的磷酸缓冲液中(10mM),使其终浓度为20μg mL-1,振荡30min后使用荧光光谱仪记录体系在355nm激发波长下425nm处的发射光强度变化。实验发现,在所测的pH范围内(5.16-9.05)β环糊精功能化碳点的荧光表现很稳定,未出现较大的波动,详细实验结果见表1。In the preliminary experiments, the fluorescence stability of β-cyclodextrin-functionalized carbon dots at different pH values was first verified. 10mM) to make the final concentration 20μg mL -1 , and after shaking for 30min, use a fluorescence spectrometer to record the change of the emission light intensity at 425nm under the excitation wavelength of 355nm. The experiment found that in the measured pH range (5.16-9.05), the fluorescence performance of β-cyclodextrin functionalized carbon dots was very stable, and there was no large fluctuation. The detailed experimental results are shown in Table 1.
表1Table 1
2.淬灭剂Fc+用量2. Quencher Fc + dosage
由上一步实验结果可知,pH对于探针的荧光强度影响不大,故选择中性pH=7.00作为后续试验条件,取一定量的β环糊精功能化碳点和不同量的Fc+溶解在pH=7.00的磷酸缓冲液中(10mM)使碳点的终浓度为20μg mL-1,而Fc+的浓度在0-500μM之间,振荡30min后使用荧光光谱仪记录体系在355nm激发波长下425nm处的发射光强度变化。由结果可见,随着Fc+的浓度的增加,体系的荧光强度逐渐下降,超过300μM以后体系的荧光强度基本维持不再变化,说明此时Fc+与β环糊精功能化碳点结合达到饱和,具体结果见下表2。From the experimental results of the previous step, it can be seen that pH has little effect on the fluorescence intensity of the probe, so neutral pH=7.00 was selected as the subsequent test conditions, and a certain amount of β-cyclodextrin functionalized carbon dots and different amounts of Fc + were dissolved in In pH=7.00 phosphate buffer (10mM), the final concentration of carbon dots was 20μg mL -1 , while the concentration of Fc + was between 0-500μM, and after shaking for 30min, the system was recorded using a fluorescence spectrometer at 425nm at an excitation wavelength of 355nm changes in the emitted light intensity. It can be seen from the results that with the increase of Fc + concentration, the fluorescence intensity of the system gradually decreased, and the fluorescence intensity of the system remained basically unchanged after more than 300 μM, indicating that the binding of Fc + to β-cyclodextrin functionalized carbon dots reached saturation at this time. , the specific results are shown in Table 2 below.
表2Table 2
3.平衡时间的影响3. The effect of equilibration time
根据上一步优化结果选择构建探针体系条件:取一定量的β环糊精功能化碳点和Fc+溶解在pH=7.00的磷酸缓冲液中(10mM)使碳点的终浓度为20μg mL-1而Fc+的浓度为320μM,振荡30min后加入一定量的睾酮标准液,使用荧光光谱仪记录体系在355nm激发波长下425nm处的发射光强度随时间的变化。由结果可知,随着加入睾酮后的时间增加体系逐渐平衡且荧光强度恢复,20min以后平衡完成荧光强度不再变化,详细结果见下表3。According to the optimization results in the previous step, the conditions for constructing the probe system were selected: take a certain amount of β-cyclodextrin functionalized Cdots and Fc + and dissolve them in phosphate buffer (10mM) at pH=7.00 to make the final concentration of Cdots 20μg mL − 1 And the concentration of Fc + was 320 μM, after shaking for 30 min, a certain amount of testosterone standard solution was added, and a fluorescence spectrometer was used to record the change of the emission light intensity at 425 nm at the excitation wavelength of 355 nm with time. As can be seen from the results, with the increase of time after adding testosterone, the system gradually balances and the fluorescence intensity recovers, and the fluorescence intensity does not change after the balance is completed after 20min. The detailed results are shown in Table 3 below.
表3table 3
五、标准方程的建立Fifth, the establishment of standard equations
在上述优化条件下取一定量的β环糊精功能化碳点和Fc+溶解在pH=7.00的磷酸缓冲液中(10mM),使碳点的终浓度为20μg mL-1,而Fc+的浓度为320μM,振荡30min后加入不同量的睾酮标准液(0-480μM),在室温下平衡20min后使用荧光光谱仪记录体系在355nm激发波长下425nm处的发射光强度的变化,结果如表4。由结果可知荧光探针体系对于0-280μM范围内变化的睾酮有着很好的相应,使用Origin对数据作图后,结果如图1所示,由图1可知,荧光探针系统对于睾酮有着很好的识别和定量分析能力,在一定范围内荧光强度与睾酮浓度之间有着良好的线性关系。线性方程为y(荧光强度,a.u.)=0.2078x(睾酮浓度,μM)+142.73。Under the above optimized conditions, a certain amount of β-cyclodextrin functionalized carbon dots and Fc + were dissolved in phosphate buffer (10 mM) at pH=7.00, so that the final concentration of carbon dots was 20 μg mL -1 , while the Fc + The concentration was 320 μM, and different amounts of testosterone standard solutions (0-480 μM) were added after oscillating for 30 min. After equilibrating at room temperature for 20 min, a fluorescence spectrometer was used to record the change of the emission light intensity at 425 nm at an excitation wavelength of 355 nm. The results are shown in Table 4. It can be seen from the results that the fluorescent probe system has a good response to testosterone that varies in the range of 0-280 μM. After plotting the data using Origin, the results are shown in Figure 1. It can be seen from Figure 1 that the fluorescent probe system has a very good response to testosterone. It has good identification and quantitative analysis ability, and has a good linear relationship between fluorescence intensity and testosterone concentration within a certain range. The linear equation is y(fluorescence intensity, au)=0.2078x(testosterone concentration, μM)+142.73.
表4Table 4
六、特异性验证6. Specificity verification
为了验证荧光探针体系对于睾酮的特异性,在优化条件下取一定量的β环糊精功能化碳点和Fc+溶解在pH=7.00的磷酸缓冲液中(10mM),使碳点的终浓度为20μg mL-1,而Fc+的浓度为320μM,振荡30min后分别加入高低水平(200、80μM)的睾酮以及其他固醇类激素物质(雄烯二酮、黄体酮、17α-羟孕酮、醋酸甲地孕酮、雌酮、雌二酮),在室温下平衡20min后使用荧光光谱仪记录体系在355nm激发波长下425nm处的发射光强度的变化,并与未加入这些物质前的原始体系荧光作比较(ΔI/I0),由结果可知,只有睾酮能在加入后较大水平改变体系荧光强度,因此体系对于睾酮有着特异性的响应。具体结果见下表5。In order to verify the specificity of the fluorescent probe system for testosterone, a certain amount of β-cyclodextrin-functionalized carbon dots and Fc + were dissolved in phosphate buffer (10 mM) at pH=7.00 under optimized conditions to make the final The concentration was 20μg mL -1 , while the concentration of Fc + was 320μM. After shaking for 30min, high and low levels (200, 80μM) of testosterone and other steroid hormones (androstenedione, progesterone, 17α-hydroxyprogesterone) were added respectively. , megestrol acetate, estrone, estradione), after equilibrating at room temperature for 20min, use a fluorescence spectrometer to record the change in the emission intensity of the system at 425nm at an excitation wavelength of 355nm, and compare it with the original system before these substances were added. The fluorescence was compared (ΔI/I 0 ), and the results showed that only testosterone could change the fluorescence intensity of the system at a large level after the addition, so the system had a specific response to testosterone. The specific results are shown in Table 5 below.
表5table 5
本领域技术人员应该理解,上文所述具体实施方式仅为了更好地理解本发明,并不用于对本发明进行限制,本发明的保护范围应以权利要求书的限定为准。Those skilled in the art should understand that the specific embodiments described above are only for better understanding of the present invention, and are not intended to limit the present invention, and the protection scope of the present invention should be defined by the claims.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910186997.7A CN109916868B (en) | 2017-03-31 | 2017-03-31 | A β-cyclodextrin functionalized carbon dot material |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910186997.7A CN109916868B (en) | 2017-03-31 | 2017-03-31 | A β-cyclodextrin functionalized carbon dot material |
CN201710206063.6A CN106872433B (en) | 2017-03-31 | 2017-03-31 | Beta-cyclodextrin functionalization carbon dots material and its applied to detection testosterone method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710206063.6A Division CN106872433B (en) | 2017-03-31 | 2017-03-31 | Beta-cyclodextrin functionalization carbon dots material and its applied to detection testosterone method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109916868A CN109916868A (en) | 2019-06-21 |
CN109916868B true CN109916868B (en) | 2020-06-12 |
Family
ID=59160450
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910186997.7A Expired - Fee Related CN109916868B (en) | 2017-03-31 | 2017-03-31 | A β-cyclodextrin functionalized carbon dot material |
CN201710206063.6A Expired - Fee Related CN106872433B (en) | 2017-03-31 | 2017-03-31 | Beta-cyclodextrin functionalization carbon dots material and its applied to detection testosterone method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710206063.6A Expired - Fee Related CN106872433B (en) | 2017-03-31 | 2017-03-31 | Beta-cyclodextrin functionalization carbon dots material and its applied to detection testosterone method |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN109916868B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111387407A (en) * | 2020-03-30 | 2020-07-10 | 云南省农业科学院农产品加工研究所 | Browning inhibitor for fruits and vegetables |
CN112886063B (en) * | 2021-02-03 | 2022-06-21 | 中南大学 | Application of a functionalized carbon dot in lithium battery electrolyte |
CN114958357B (en) * | 2021-02-20 | 2023-04-28 | 重庆医科大学 | Visible and near infrared light region double-emission fluorescent carbon dot and preparation method thereof |
CN115975638B (en) * | 2023-01-09 | 2024-06-04 | 云南民族大学 | Carbon quantum dots for detecting mercury ions and/or iron ions in aqueous solution and applications thereof |
CN116925755B (en) * | 2023-07-20 | 2024-05-28 | 中国石油大学(北京) | Preparation method of ferric ion doped carbon point, fluorescent probe and fluorescence detection method of indium ions |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949721A (en) * | 2011-08-24 | 2013-03-06 | 天津金耀集团有限公司 | Transdermal absorption pharmaceutical composition containing testosterone and NOS inhibitor |
CN103149186A (en) * | 2013-02-06 | 2013-06-12 | 中国药科大学 | Aromatase inhibitor high-throughput screening model based on fluorescence detection principle |
CN103864055A (en) * | 2013-12-13 | 2014-06-18 | 广西师范学院 | Method for rapidly preparing fluorescent carbon dots |
CN104530417A (en) * | 2014-10-01 | 2015-04-22 | 厦门赛诺邦格生物科技有限公司 | Multifunctional H-type polyethylene glycol derivative and preparation method thereof |
CN104530413A (en) * | 2014-10-01 | 2015-04-22 | 厦门赛诺邦格生物科技有限公司 | Biologically related substances modified by multifunctional H-type polyethylene glycol derivative |
WO2016050351A1 (en) * | 2014-09-30 | 2016-04-07 | Freie Universität Berlin | Controlled functionalization of carbon based nanomaterials |
CN105675559A (en) * | 2016-01-14 | 2016-06-15 | 中国科学院理化技术研究所 | Method for detecting dopamine by using carbon dots as fluorescent probes |
CN105891309A (en) * | 2016-04-05 | 2016-08-24 | 广西师范学院 | Method for detecting concentration of L-tryptophan in solution |
CN106124781A (en) * | 2016-07-07 | 2016-11-16 | 中国农业科学院农业质量标准与检测技术研究所 | A kind of method based on aptamers sandwich fluorescent quenching technology for detection demethyl testosterone |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102168138B (en) * | 2011-02-23 | 2013-06-12 | 中山大学 | Method for detecting androgen in environment |
CN102220128B (en) * | 2011-04-21 | 2013-08-21 | 江苏迈健生物科技发展有限公司 | Low-toxicity functionalized quantum dot modified by amination beta-cyclodextrin and preparation method thereof |
EP3129065A4 (en) * | 2014-03-12 | 2018-01-24 | Invictus Oncology Pvt. Ltd. | Targeted drug delivery through affinity based linkers |
CN106248644B (en) * | 2016-08-02 | 2019-04-19 | 江南大学 | A method for the determination of alkaline phosphatase based on carbon dot fluorescence "quenching-recovery" |
-
2017
- 2017-03-31 CN CN201910186997.7A patent/CN109916868B/en not_active Expired - Fee Related
- 2017-03-31 CN CN201710206063.6A patent/CN106872433B/en not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949721A (en) * | 2011-08-24 | 2013-03-06 | 天津金耀集团有限公司 | Transdermal absorption pharmaceutical composition containing testosterone and NOS inhibitor |
CN103149186A (en) * | 2013-02-06 | 2013-06-12 | 中国药科大学 | Aromatase inhibitor high-throughput screening model based on fluorescence detection principle |
CN103864055A (en) * | 2013-12-13 | 2014-06-18 | 广西师范学院 | Method for rapidly preparing fluorescent carbon dots |
WO2016050351A1 (en) * | 2014-09-30 | 2016-04-07 | Freie Universität Berlin | Controlled functionalization of carbon based nanomaterials |
CN104530417A (en) * | 2014-10-01 | 2015-04-22 | 厦门赛诺邦格生物科技有限公司 | Multifunctional H-type polyethylene glycol derivative and preparation method thereof |
CN104530413A (en) * | 2014-10-01 | 2015-04-22 | 厦门赛诺邦格生物科技有限公司 | Biologically related substances modified by multifunctional H-type polyethylene glycol derivative |
CN105675559A (en) * | 2016-01-14 | 2016-06-15 | 中国科学院理化技术研究所 | Method for detecting dopamine by using carbon dots as fluorescent probes |
CN105891309A (en) * | 2016-04-05 | 2016-08-24 | 广西师范学院 | Method for detecting concentration of L-tryptophan in solution |
CN106124781A (en) * | 2016-07-07 | 2016-11-16 | 中国农业科学院农业质量标准与检测技术研究所 | A kind of method based on aptamers sandwich fluorescent quenching technology for detection demethyl testosterone |
Non-Patent Citations (2)
Title |
---|
A fluorometric assay for alkaline phosphatase activity based on β-cyclodextrin-modified carbon quantum dots through host-guest recognition;Cong Tang.et;《Biosensors and Bioelectronics》;20160419;第83卷;第274-280页 * |
荧光碳点对Fe3+的检测研究;李国平等;《闽南师范大学学报(自然科学版)》;20151231(第3期);第47-52页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106872433A (en) | 2017-06-20 |
CN106872433B (en) | 2019-03-08 |
CN109916868A (en) | 2019-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109916868B (en) | A β-cyclodextrin functionalized carbon dot material | |
Yang et al. | A quadruplet electrochemical platform for ultrasensitive and simultaneous detection of ascorbic acid, dopamine, uric acid and acetaminophen based on a ferrocene derivative functional Au NPs/carbon dots nanocomposite and graphene | |
Han et al. | One-step synthesis of graphene oxide–thionine–Au nanocomposites and its application for electrochemical immunosensing | |
Li et al. | Electrogenerated chemiluminescence detection of amino acids based on precolumn derivatization coupled with capillary electrophoresis separation | |
Nevado et al. | Spectrofluorimetric study of the β-cyclodextrin: vitamin K3 complex and determination of vitamin K3 | |
Elmizadeh et al. | Fluorescent apta-nanobiosensors for fast and sensitive detection of digoxin in biological fluids using rGQDs: Comparison of two approaches for immobilization of aptamer | |
Gholivand et al. | An electrochemical sensor for warfarin determination based on covalent immobilization of quantum dots onto carboxylated multiwalled carbon nanotubes and chitosan composite film modified electrode | |
CN104502614B (en) | A kind of based on gold nanoclusters analogue enztme kit and preparation method thereof and application | |
Kumar et al. | Palladium nano particles decorated multi-walled carbon nanotubes modified sensor for the determination of 5-hydroxytryptophan in biological fluids | |
CN107064264A (en) | A kind of construction method for being used to detect the optical electro-chemistry sensor of dopamine without enzyme | |
CN110658168B (en) | Method for detecting testosterone by gold nanocluster-gold nanorod immunosensor | |
Alhazzani et al. | A reliable ratiometric fluorescence sensing of heparin and its antidote based on cationic carbon quantum dots and acid red 87 | |
Xie et al. | Sensitive SERS detection of SARS-CoV‑2 spike protein based on Y‑shaped-aptasensor and AuNPs/COFs composites | |
CN102175736A (en) | Enzyme electrode for detecting sterigmatocystin and preparation and application thereof | |
Guo et al. | Studies on the non‐covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectrometry | |
Ghani et al. | Novel synthesis of a dual fluorimetric sensor for the simultaneous analysis of levodopa and pyridoxine | |
CN108037101A (en) | A kind of preparation and application of the water-soluble fluorescent carbon point sensor that can detect formaldehyde | |
Guo et al. | Recent advances in β-cyclodextrin-based materials for chiral recognition | |
CN110308188A (en) | Gold-platinum co-modified graphene electrode and its preparation method and application | |
Pinilla-Peñalver et al. | Cyclodextrin-modified graphene quantum dots as a novel additive for the selective separation of bioactive compounds by capillary electrophoresis | |
Wu et al. | Fabrication of a ratiometric electrochemiluminescence biosensor using single self-enhanced nanoluminophores for the detection of spermine | |
CN111363542B (en) | Full-color fluorescent CaF 2 And use of CaF 2 Prepared furfural molecular imprinting ratio fluorescence sensor and preparation method thereof | |
Luo et al. | Novel electrochemiluminescence resonance energy transfer platform involving PTCA@ Fe (III)-MIL-88B-NH2@ Au as a double-amplified emitter for the detection of cystatin C | |
Chaichi et al. | Chitosan-induced Au/Ag nanoalloy dispersed in IL and application in fabricating an ultrasensitive glucose biosensor based on luminol–H2O2–Cu2+/IL chemiluminescence system | |
Ding et al. | Dual-mode cholesterol sensor based on gold nanorods and carbon quantum dots |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200612 |
|
CF01 | Termination of patent right due to non-payment of annual fee |